Takeda Pharmaceuticals America, Inc.

Adzynma

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Takeda Pharmaceuticals America, Inc.

Adzynma HCPCS:

J7171

HCPCS Code Descriptor:

Inj, adzynma, 10 iu

Category:

J Code

Adzynma NDCs:

64764-0140-05, 64764-0145-05

Primary Type:

Anti-Eosinophil Asthma

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Adzynma CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Adzynma:

Adzynma is a medication manufactured by Takeda Pharmaceuticals America, Inc. and aligned to the J Code: J7171. Adzynma is administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7171 Added Date:

1-Jul-24

J7171 Effective Date:

1-Jul-24

J7171 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Adzynma
Patient assistance information for Adzynma can be found through Takeda Patient Support at the following URL: https://www.takedapatientsupport.com/s/
Adzynma prescribing information can be found at the link below:
Our team did not identify a source of side effect information for Adzynma.